MedPath

Hypertension Approaches in the Elderly: a Lifestyle Study

Not Applicable
Conditions
Hypertension
Interventions
Behavioral: Health education
Behavioral: Combined training
Registration Number
NCT03264443
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Two-center randomized, parallel, controlled trial which will compare a pragmatic combined training program with a health education program in 184 older adults with hypertension. This study will last 12 weeks with assessments conducted at baseline, previously to the group allocation, and after interventions. There is a set of secondary outcomes which show clinical importance to the elderly population and are possibly influenced by the tested intervention.

Detailed Description

The present protocol describes a randomized controlled trial that aims to evaluate blood pressure effects of a pragmatic combined training program, with low equipment needs, in comparison with a health education program. The sample is composed by 184 older adults, divided in two implementation centers. Randomization ratio will be 1:1 and interventions will last 12 weeks, with three weekly sessions for the exercise arm and one to the health education arm. In order to analyze the effects of interventions in a comprehensive way, a range of variables related to ambulatory blood pressure (primary outcome), physical fitness, vascular and autonomous function, together with emotional and cognitive aspects will be evaluated in a pre-post fashion. The study's hypothesis, as well as the sample size calculation and analysis plan, is based on a superiority expectation for the exercise program in comparison with the health education program, especially for the blood pressure control, functional capacity and quality of life. The present study was designed and will be conducted by a multidisciplinary staff and follows ethical and methodological recommendations for clinical trials. It is expected that this multicenter randomized trial will provide scientific evidences with a high applicability to the non-pharmacological management of hypertension in the elderly.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
184
Inclusion Criteria
  • Hypertension diagnosis (through ambulatory blood pressure monitoring or medication use)
  • Verified ability to exercise
  • Unaltered pharmacological plan within previous 4 weeks
  • Willingness to participate in any of interventions
Exclusion Criteria
  • Inability or refusal to give written consent
  • Myocardial infarction, revascularization proceedings, deep vein thrombosis
  • Severe cardiovascular disease (class III or IV heart failure, uncontrolled arrhythmia, unstable angina, or use of implantable defibrillator
  • Chronic pulmonary disease which requires the use of oxygen or steroidal therapy
  • Incidence of cardiovascular event, hospitalization or other severe health-related event during the experimental period
  • High alcohol consumption (over 14 doses per week)
  • Renal disease needing dialysis
  • Language, cognitive or hearing problems
  • Plans of moving to another city during the study
  • Living together with another person enrolled in the study
  • Osteoarticular or muscular injuries or another health conditions which generate inability to carry on the interventions
  • Progressive neurological disorders (Parkinson, multiple sclerosis, etc.)
  • Cancer treatment in the past 2 years
  • A medical report indicating exercise counterindication based cardiopulmonary exercise testing

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Health educationHealth educationPatients will receive weekly lectures on hypertension related topics during 12 weeks.
Combined trainingCombined trainingPatients will complete 12 weeks of combined training (aerobic + strength exercise, 3x/week) in a pragmatic setup. In order to make the interventions more similar, contents of the health education arm will also be discussed with patients receiving this intervention.
Primary Outcome Measures
NameTimeMethod
Ambulatory Blood PressureChange from baseline 24-hour systolic blood pressure at 12 weeks

24h ambulatory blood pressure measured through automatic oscillometric device

Secondary Outcome Measures
NameTimeMethod
Geriatric Depression SymptomsChange from baseline GDS-15 score at 12 weeks

15-item depression symptoms scale (GDS-15)

Quality of life (QoL)Change from baseline QoL score at 12 weeks

World Health Organization Quality of Life questionnaire

Autonomic functionChange from baseline beat-to-beat blood pressure variability at 12 weeks

Basal and during Stroop Color-Word Conflict Test beat-to-beat blood pressure variability

Endothelial function, early adaptationChange from baseline FMD at 6 weeks

Flow-mediated dilatation (FMD) assessed through high resolution ultrasonography

Endothelial functionChange from baseline FMD at 12 weeks

Flow-mediated dilatation (FMD) assessed through high resolution ultrasonography

Walking distanceChange from baseline walking distance at 12 weeks

Longest distance walked as assessed by the six-minute walk test

Lower limbs functional capacityChange from baseline SPPB score at 12 weeks

By using the Short Physical Performance Battery (SPPB), lower-limb mobility will be assess in the following sequence: static standing balance, walking speed and indirect muscle strength

Cardiorespiratory fitnessChange from baseline VO2peak at 12 weeks

Oxygen consumption at peak (VO2peak) as assessed by maximal cardiopulmonary exercise testing

Trial Locations

Locations (2)

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Universidade Federal de Pelotas

🇧🇷

Pelotas, Rio Grande Do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath